Haluk Gumus Selected Research

Myelin-Oligodendrocyte Glycoprotein

2/2022

The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haluk Gumus Research Topics

Disease

2	Pain (Aches) 10/2012 - 04/2009
1	Nervous System Diseases (Neurological Disorders) 07/2023
1	Insulin Resistance 09/2022
1	Memory Disorders (Memory Loss) 09/2022
1	COVID-19 02/2022
1	Neuromyelitis Optica (Devic's Disease) 02/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2013
1	Hyperhomocysteinemia 01/2013
1	Homocystinuria 01/2013
1	Myoclonus (Nocturnal Myoclonus) 04/2010
1	Hemorrhage 04/2009
1	Nausea 04/2009
1	Postoperative Pain 04/2009
1	Vomiting 04/2009
1	Ataxia (Dyssynergia) 07/2008

Drug/Important Bio-Agent (IBA)

2	ZincIBA 07/2023 - 09/2022
2	Analgesics (Analgesic Drugs)IBA 10/2012 - 04/2009
1	Myelin-Oligodendrocyte GlycoproteinIBA 02/2022
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2013
1	Lidocaine (Xylocaine)FDA LinkGeneric 04/2010
1	Etomidate FDA LinkGeneric 04/2010
1	Tramadol (K315)FDA LinkGeneric 04/2009
1	Doxycycline (Periostat)FDA LinkGeneric 07/2008
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2008
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 07/2008

Therapy/Procedure

1	Analgesia 04/2009